Rheumnow Podcast

Join our topic panel discussion on Psoriatic Arthritis!

Join us live for our daily recap of ACR2023!

Featuring panelists Dr. Kathryn Dao, Eric Dein and Sheila Reyes, discussing the best and most interesting lupus studies presented at the 2023 ACR Convergence meeting in San Diego, CA.

Bimekizumab in Active AS_ 5 Year Study INVIGORATE-1 Study_ IV Secukinumab for Treatment of Active axSpA Overlap of Inflammatory and Degenerative Features in Radiographic axSpA People with AxSpa Need More Sleep

Does Diet Matter in RA_ ITIS vs Mediterranean diet EHR Algorithms Identify PsA Patients JAK1 TYK2 in RA Older RA Patients Just Aren't Getting Treated PR3+ in Lupus Nephritis Racial and Ethnic Differences in Efficacy of Beliumumab in SLE Steroids and MACE in RA Unravelling the Mechanism of Clots with JAK Inhibitors

Join our live stream panel discussion as we dive deep into the highlights and key takeaways from day one of ACR 2023.

Cannabinoid Receptor in RA Patients Cardiac Troponin T and MACE Events in RA Imaging Updates in SpA Impact of Tofacitinib on Skeletal Muscle in RA Teledidactic vs On Campus Training in Musculoskeletal Ultrasound Treatments in SpA

Identifying New Biomarkers in the Pathogenesis of SLE-PAH No Increased Mortality in Patients with RA Receiving Checkpoint Inhibitors Simulated JAK Trials to Counter ORAL Survelliance The FOREMOST Study_ Apremilast in PsA The SMART Study_ Split Dose Oral Methotrexate Upadacitinib for Pain_ Is That Real_

Head to Head Comparison of Tofacitinib and TLL-018 in RA Non-TNFi b_tsDMARDs vs. TNFi in RA-ILD People with RA and Long COVID Had Worse Pre-COVID RA Symptoms Reproductive History, HPV Vaccination Among Women with SLE and  RA Secukinumab vs. Adalimumab Biosimilar on Radiographic Progression in AxSpA The SMART Study_ Split Dose Oral Methotrexate Undiagnosed IBD in AxSpA Using Telemedicine to Improve Diagnosis of AxSpA Window of Opportunity in PsA

An Interview with Kevin Winthrop_ Three Questions About COVID 19 Biologics in RA_ Mechanisms of Delivery Over Mechanisms of Action_ (1) Deep Neural Networks and Radiographic Progression in AxSpA Difficult to Treat axSpA Does GnRHa Reduce Premature Ovarian Insufficiency in SLE Patients on Cyclophosphamide_ Factors Associated with Discontinuation of TNFs in AxSpA From AS Patient to Rheumatologist